Cargando…
Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
Amyloidosis is a disorder of protein misfolding and metabolism in which insoluble fibrils are deposited in various tissues, causing organ dysfunction and eventually death. Out of the 60-plus heterogeneous amyloidogenic proteins that have been identified, approximately 30 are associated with human di...
Autor principal: | Baker, Kelty R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932379/ https://www.ncbi.nlm.nih.gov/pubmed/35414848 http://dx.doi.org/10.14797/mdcvj.1070 |
Ejemplares similares
-
Global epidemiology of amyloid light-chain amyloidosis
por: Kumar, Nishant, et al.
Publicado: (2022) -
Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018) -
Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017) -
Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021) -
Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
por: Stelmach-Gołdyś, Agnieszka, et al.
Publicado: (2022)